Reviewer's report
Title:Multicenter Comparison of PEG-IFN 2a or 2b Plus Ribavirin for
Treatment-naive HCV Patient in Korean Population
Version: 2Date:18 March 2013
Reviewer: Steffen Zopf
Reviewer's report:
My comments have been addressed.
Level of interest: An article whose findings are important to those with closely
related research interests
Quality of written English: Acceptable
Statistical review: Yes, but I do not feel adequately qualified to assess the
statistics.
Declaration of competing interests:
I have received lecture and consulting fees from MSD and Roche.
Reviewer's report
Title:Multicenter Comparison of PEG-IFN 2a or 2b Plus Ribavirin for
Treatment-naive HCV Patient in Korean Population
Version: 2Date:18 March 2013
Reviewer: Steffen Zopf
Reviewer's report:
My comments have been addressed.
Level of interest: An article whose findings are important to those with closely
related research interests
Quality of written English: Acceptable
Statistical review: Yes, but I do not feel adequately qualified to assess the
statistics.
Declaration of competing interests:
I have received lecture and consulting fees from MSD and Roche.
Please review this paper.
user
Reviewer's report
Title:Multicenter Comparison of PEG-IFN 2a or 2b Plus Ribavirin for
Treatment-naive HCV Patient in Korean Population
Version: 2Date:18 March 2013
Reviewer: Steffen Zopf
Reviewer's report:
My comments have been addressed.
Level of interest: An article whose findings are important to those with closely
related research interests
Quality of written English: Acceptable
Statistical review: Yes, but I do not feel adequately qualified to assess the
statistics.
Declaration of competing interests:
I have received lecture and consulting fees from MSD and Roche.
assistant